retatrutide clinical trial results 2024 Incretin-based therapies for the treatment of obesity-related diseases Lilly's triple agonist, retatrutide, successful
Pay in 4 interest-free payments of $5.27 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5























